Samsung
Biologics likely to
seek IPO
approval this week-bourse officials
SEOUL (Reuters) -
Samsung Biologics Co Ltd is expected to apply for stock exchange
approval this week for its IPO, two
officials with the Seoul bourse said, as part of its bid to become the world's...
